4.6 Article

Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Neurosciences

Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy

Hana Starobova et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)

Article Oncology

Patient-reported outcomes in the evaluation of toxicity of anticancer treatments

Massimo Di Maio et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

Article Medicine, General & Internal

Minimally important difference estimates and methods: a protocol

Bradley C. Johnston et al.

BMJ OPEN (2015)

Article Education, Scientific Disciplines

Patient-reported outcomes in clinical practice

Sarah Dobrozsi et al.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2015)

Review Oncology

Chemotherapy-induced neuropathy: A comprehensive survey

N. C. Miltenburg et al.

CANCER TREATMENT REVIEWS (2014)

Review Oncology

Management options for established chemotherapy-induced peripheral neuropathy

Deirdre R. Pachman et al.

SUPPORTIVE CARE IN CANCER (2014)

Review Oncology

Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature

Andreas A. Argyriou et al.

CANCER MANAGEMENT AND RESEARCH (2014)

Review Health Care Sciences & Services

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

Dennis Revicki et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)

Article Health Care Sciences & Services

Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience

KJ Yost et al.

EVALUATION & THE HEALTH PROFESSIONS (2005)

Article Health Care Sciences & Services

Methods for assessing responsiveness: a critical review and recommendations

JA Husted et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)